Literature DB >> 12135815

Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis.

István Karádi1, Zsuzsa Mészáros, Attila Csányi, Tamás Szombathy, Nóra Hosszúfalusi, László Romics, Kálmán Magyar.   

Abstract

BACKGROUND: Clinical and experimental studies suggest that increased activity of semicarbazide-sensitive amine oxidase (SSAO) and the production of cytotoxic metabolites (e.g., formaldehyde and hydrogen peroxide) may play an important role in the pathogenesis of atherosclerosis. The present study was designed to assess the relationship between the increased activity of the enzyme and the severity of atherosclerosis in diabetic and control subjects.
METHODS: The study included 29 patients with type 2 diabetes mellitus and 25 control subjects. Human serum SSAO activity was determined by using 14C-benzylamine as substrate. Mean common carotid intima-media thickness (IMT), Crouse score and Bogousslawsky score was evaluated by color-coded, high-resolution duplex carotid sonography.
RESULTS: Serum SSAO activity was significantly increased in patients with type 2 diabetes compared to controls. Carotid plaque score (Crouse score), total cholesterol level and age-corrected intima-media thickness showed positive correlation with enzyme activity in control subjects. In patients with diabetes, serum SSAO activity correlated with the severity of carotid stenosis (Bogousslawsky score) as well as the carotid plaque score.
CONCLUSIONS: Determination of serum SSAO activity might be a candidate biochemical marker of early atherosclerosis and diabetic macrovascular complications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135815     DOI: 10.1016/s0009-8981(02)00189-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  17 in total

1.  Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease.

Authors:  M Unzeta; M Solé; M Boada; M Hernández
Journal:  J Neural Transm (Vienna)       Date:  2007-03-29       Impact factor: 3.575

2.  The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model.

Authors:  A G Jarnicki; H Schilter; G Liu; K Wheeldon; A-T Essilfie; J S Foot; T T Yow; W Jarolimek; P M Hansbro
Journal:  Br J Pharmacol       Date:  2016-10-12       Impact factor: 8.739

3.  Anatomical distribution of primary amine oxidase activity in four adipose depots and plasma of severely obese women with or without a dysmetabolic profile.

Authors:  Christian Carpéné; Francisco Les; Mounia Hasnaoui; Simon Biron; Picard Marceau; Denis Richard; Jean Galitzky; Denis R Joanisse; Pascale Mauriège
Journal:  J Physiol Biochem       Date:  2016-10-21       Impact factor: 4.158

4.  Alteration of serum semicarbazide-sensitive amine oxidase activity in chronic renal failure.

Authors:  J Nemcsik; E Szökö; Zs Soltész; E Fodor; L Toth; J Egresits; T Tábi; K Magyar; I Kiss
Journal:  J Neural Transm (Vienna)       Date:  2007-04-13       Impact factor: 3.575

5.  Circulating vascular adhesion protein-1(VAP-1): a possible biomarker for liver fibrosis associated with chronic hepatitis B and C.

Authors:  Zehra Öksüz; Enver Üçbilek; Mehmet Sami Serin; Serkan Yaraş; Gülhan Orekici Temel; Orhan Sezgin
Journal:  Braz J Microbiol       Date:  2020-09-21       Impact factor: 2.476

6.  A comparison between radiometric and fluorimetric methods for measuring SSAO activity.

Authors:  Alejandro Gella; Montse Solé; Irene Bolea; Mariacarla Ventriglia; Mariacristina Siotto; Nuria Durany; Rosanna Squitti; Mercedes Unzeta
Journal:  J Neural Transm (Vienna)       Date:  2013-02-12       Impact factor: 3.575

7.  Crystallization of a truncated soluble human semicarbazide-sensitive amine oxidase.

Authors:  Emma Jakobsson; Joakim Nilsson; Ulla Källström; Derek Ogg; Gerard J Kleywegt
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-02-08

8.  Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine.

Authors:  Dmitriy Matveychuk; Emerson Nunes; Nasir Ullah; Carlos A Velázquez-Martinez; Erin M MacKenzie; Glen B Baker
Journal:  J Neural Transm (Vienna)       Date:  2013-02-08       Impact factor: 3.575

Review 9.  Hepatic consequences of vascular adhesion protein-1 expression.

Authors:  Chris J Weston; David H Adams
Journal:  J Neural Transm (Vienna)       Date:  2011-04-22       Impact factor: 3.575

10.  Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis.

Authors:  Chris J Weston; Emma L Shepherd; Lee C Claridge; Pia Rantakari; Stuart M Curbishley; Jeremy W Tomlinson; Stefan G Hubscher; Gary M Reynolds; Kristiina Aalto; Quentin M Anstee; Sirpa Jalkanen; Marko Salmi; David J Smith; Christopher P Day; David H Adams
Journal:  J Clin Invest       Date:  2014-12-22       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.